Moleculin Announces New Annamycin Collaboration in Brain Tumors

Go back to Moleculin Announces New Annamycin Collaboration in Brain Tumors
METABASIS THERAPEUT (NASDAQ: MBRX) Delayed: 0.60 --0 (-0%)
Previous Close $0.60    52 Week High $9.58 
Open $0.60    52 Week Low $2.34 
Day High $0.60    P/E N/A 
Day Low $0.60    EPS $-0.34 
Volume 34,363